Insights - BIO

Areas of Work

	BIO CEO & Investor Conference 2003 Media Registration Now Available Online Jan 28 2003 WASHINGTON, D.C. (January 28, 2003) — Media registration is now open for the Biotechnology Industry Organization’s (BIO) CEO & Investor Conference 2003, February 25-27 at the Waldorf-Astoria in...
	FDA Commissioner McClellan To Speak at BIO CEO Conference Jan 28 2003 WASHINGTON, D.C. (January 28, 2003) – Food and Drug Administration (FDA) Commissioner Mark B. McClellan, M.D., Ph.D., will speak at the Biotechnology Industry Organization’s (BIO) fifth annual CEO ...
	New BIO Science and Regulatory Department to be headed by Dr. Gillian R. Woollett Jan 24 2003 Washington, D.C. (January 24, 2003) – Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO) today announced the establishment of a new Science and Regulatory Affairs...
	BIO Introduces Financial Community to Industrial Biotechnology Jan 22 2003 Washington, D.C. (January 22, 2003) - Wall Street analysts and investors will get their first glimpse of the multibillion-dollar industrial biotechnology sector and how it is revolutionizing...
	FDA Approves 20 New Biotech Products, 15 New Indications Jan 9 2003 Washington, D.C. (January 9, 2003) - The Food and Drug Administration (FDA) approved 35 new biotechnology-based drugs and vaccines as well as new indications for previously approved products in...
	The Third Wave of Biotechnology –Industrial- Investor Briefing Scheduled Jan 8 2003 Washington, D.C. (January 8, 2003) – The Biotechnology Industry Organization (BIO) will address the market potential for industrial biotechnology during an analyst and investor briefing, The Third...
	BIO Statement on Human Cloning Dec 27 2002 WASHINGTON, D.C. (December 27, 2002) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today issued the following statement on reports that the first human...
	Medicare Patients Face a New Year With Yesterday’s Medicines Dec 18 2002 Washington, D.C. (December 18, 2002) – “A new CMS rule slated to take effect January 1 will leave some Medicare patients with yesterday’s medicines,” said Carl B. Feldbaum,...
	BIO Announces First Annual Industrial Biotechnology Analyst and Investor Briefing Dec 17 2002 Washington, DC (December 17, 2002) – The Biotechnology Industry Organization (BIO) is pleased to announce the First Annual Industrial Biotechnology Analyst and Investor Briefing to be held...
	BIO Names Kathy Stover as New Communications Director Dec 16 2002 WASHINGTON, D.C. (December 16, 2002) − Kathy Stover is the new director of communications for the Biotechnology Industry Organization (BIO) effective today. In the position, Stover will...